Most recently, a study has discovered frequent inactivating mutations in multiple chromatin-remodeling genes in ICC [9], and another study has also revealed recurrent novel FGFR2 fusions and ERRFI mutations in ICC [10]. This evidence concerns the gene FGFR2 and intrahepatic cholangiocarcinoma.